Electrical Stimulation Devices Show Proven Results Against Chronic Pain

According to a study published by American Chiropractic Association in 2020, approximately, 31 million Americans suffer from lower back pain at some point of time in their lives. Factors including genetic conditions, aging, mental stress, sedentary lifestyle, and surgical interventions are among of the prominent factors that cause chronic pain. It not only affects the social life of patient but also damages his/her economic aspects.

The patients with acute pain now can be treated with the help of various therapeutic solutions but the case is not same when any patient suffers from the chronic pain. There is no specific treatment available to cure chronic pain. On the other side, without treatment, patient may suffer from prolonged condition of abnormality. That’s why healthcare system considers chronic pain is one of the major problems.

But, in recent years, electrical stimulation devices are being utilized to treat chronic pain with the help of electrical signals. For instance, with the launch of Spectra WaveWriter Spinal Cord Stimulator (SCS) System, Boston Scientific Corporation claimed that this system is capable of providing great relief to chronic pain.

Additionally, with advanced technologies, these devices enable the customization of therapy and its real-time monitoring. Industry analysts opine that these benefits coupled with rising prevalence of chronic pain are driving the growth of the electrical stimulation devices market.

Deep brain stimulation devices, spinal cord stimulation devices, SNS devices, GES devices, VNS devices, TENS devices, and NMES/EMS devices are currently available in the market. The spinal cord stimulation devices dominated the market in 2019. Whereas, experts predict that sacral nerve stimulation (SNS) devices will register the highest CAGR in the market between 2020 and 2027.

Strategic activities such as product launches and approval by regulators are commonly performed by companies to meet the rising demands and expand product portfolio worldwide. Now, some of the major companies including Boston Scientific Corporation, Medtronic, Abbott, BTL, and DJOGlobal, Inc. are dominating the electrical stimulation devices market.

The research report published by The Insight Partners predicts that the electrical stimulation devices market will grow to US$ 11,334.0 million by 2027 at a CAGR of 9.3% between 2020 and 2027. The report also states that the factors including increasing awareness regarding the efficient outcomes of electrical stimulation therapy and availability of various approved devices are bolstering the market growth.